Laniten Tablet 125mg (Terbinafine Hydrochloride)

Adult dosage

As terbinafine: 125 mg once, twice a day, or 250 mg once a day. The treatment duration varies by condition: - Dermatophytosis - Tinea pedis (interdigital type, plantar type/moctail type): 2-6 weeks - Tinea corporis: 2-4 weeks - Tinea cruris (jock itch): 2-4 weeks - Onychomycosis - Typically treated for 6 weeks to 3 months. - If infected nails or relatively smaller toenails are involved, or if the patient is younger, the treatment duration may be shortened to less than 3 months. Treatment duration for toenail infections is usually sufficient at 3 months, but some patients may require longer, such as 6 months or more, depending on the rate of nail growth. 2. Pediatrics: Administered to children over 2 years old. There is no experience with administration in children under 2 years old, so administration is not recommended. Tinea capitis: 4 weeks. Tinea capitis primarily occurs in children. To prevent recurrence of infection, treatment should be done regularly for the appropriate specified duration. 1) Weight under 20 kg (under 5 years): 62.5 mg once daily. Due to insufficient experience with administration, the benefits and risks of treatment should be considered before deciding whether to administer. 2) Weight 20-40 kg (5-12 years): 125 mg once daily. 3) Weight over 40 kg (over 12 years): 250 mg once daily. 3. Patients with renal impairment For patients with a creatinine clearance of less than 50 mL per minute, the daily dose should be reduced by half.

Children's dosage

Administered to children over 2 years old. There is no experience with administration in children under 2 years old, so administration is not recommended. Tinea capitis: 4 weeks. 1) Weight under 20 kg (under 5 years): 62.5 mg once, 1

This medication is not recommended for patients with chronic liver disease or active liver disease. Liver function status must be checked prior to administration, and regular liver function tests should be performed during treatment. If liver function deteriorates, discontinue medication immediately, and inform a doctor if symptoms such as nausea, loss of appetite, fatigue, vomiting, abdominal pain, or jaundice occur. This medication should not be administered to individuals with blood disorders, severe renal failure, children under 2 years old, nursing mothers, and patients with certain genetic disorders. Use with caution in the elderly, patients with impaired renal function, and underweight children; if severe skin rash or allergic reactions occur, discontinue immediately. This medication can cause side effects affecting the liver, blood, skin, musculoskeletal system, gastrointestinal tract, and nervous system; consult a physician if any unusual symptoms arise. Symptoms such as dizziness may occur when driving or operating machinery, so caution is necessary. Potential interactions with other medications may occur, so inform your doctor or pharmacist of any other medications being taken, as dosage adjustments may be necessary. Women who are pregnant or may become pregnant should use this medication cautiously, and nursing mothers should discontinue breastfeeding. Overdosage may result in symptoms such as headache, nausea, abdominal pain, dizziness, and appropriate medical attention should be sought immediately. This medication should be stored out of reach of children, protected from direct sunlight, and kept at room temperature.

Serious side effects

Hepatobiliary failure, hepatitis, cholestasis, jaundice, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, mucocutaneous syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome), acute generalized exanthematous pustulosis, anaphylactic reaction (including angioedema, systemic lupus erythematosus), severe skin reactions, severe hepatic failure, severe edema accompanied by hypertension, rhabdomyolysis, dyspnea, chest tightness, hypotension,

Mild side effects

Rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, photosensitivity reactions, acute generalized exanthematous pustulosis, erythema multiforme, toxic epidermal necrolysis (Lyell's syndrome), alopecia, arthralgia, myalgia, weakness, elevated CPK, increased myoglobin in blood and urine, hypotension, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea,

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is recommended to store the medication at a cool room temperature, specifically between 1 to 30 degrees Celsius.

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle